Unknown

Dataset Information

0

Rufomycin Exhibits Dual Effects Against Mycobacterium abscessus Infection by Inducing Host Defense and Antimicrobial Activities.


ABSTRACT: Nontuberculous mycobacterial pulmonary infection is often aggravated due to antibiotic resistance issues. There is a need for development of new drugs inducing both host immune responses and antimicrobial activities. This study shows that the rufomycins 4/5/6/7 (Rufomycin 4-7), which targets ClpC1 as a subunit of caseinolytic protein complex ClpC1/ClpP1/ClpP2 of mycobacteria, exhibits a dual effect in host innate defense and in vivo antimicrobial activities against a rough morphotype of Mycobacterium abscessus (Mabs-R), a clinically severe morphotype that causes hyperinflammation. Rufomycin 4-7 treatment showed antimicrobial effects against Mabs pulmonary infection in vivo and in macrophages. In addition, Rufomycin 4-7 significantly decreased inflammation, but enhanced the autophagy/lysosomal genes through upregulation of the nuclear translocation of transcription factor EB (TFEB). Furthermore, Rufomycin 4-7 treatment effectively inhibited mitochondrial damage and oxidative stresses in macrophages during Mabs-R infection. Collectively, Rufomycin 4-7-mediated dual effects inducing both antimicrobial activities and host immune defense might confer an advantage to treatment against Mabs-R infection.

SUBMITTER: Park CR 

PROVIDER: S-EPMC8383285 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rufomycin Exhibits Dual Effects Against <i>Mycobacterium abscessus</i> Infection by Inducing Host Defense and Antimicrobial Activities.

Park Cho Rong CR   Paik Seungwha S   Kim Young Jae YJ   Kim Jin Kyung JK   Jeon Sang Min SM   Lee Sang-Hee SH   Whang Jake J   Cheng Jinhua J   Suh Joo-Won JW   Cao Jin J   Shetye Gauri G   Chen Shao-Nong SN   McAlpine James J   Pauli Guido F GF   Franzblau Scott S   Cho Sanghyun S   Jo Eun-Kyeong EK  

Frontiers in microbiology 20210810


Nontuberculous mycobacterial pulmonary infection is often aggravated due to antibiotic resistance issues. There is a need for development of new drugs inducing both host immune responses and antimicrobial activities. This study shows that the rufomycins 4/5/6/7 (Rufomycin 4-7), which targets ClpC1 as a subunit of caseinolytic protein complex ClpC1/ClpP1/ClpP2 of mycobacteria, exhibits a dual effect in host innate defense and <i>in vivo</i> antimicrobial activities against a rough morphotype of <  ...[more]

Similar Datasets

| S-EPMC6395927 | biostudies-literature
| S-EPMC7526805 | biostudies-literature
| S-EPMC3491551 | biostudies-literature
| S-EPMC11479615 | biostudies-literature
| S-EPMC8592419 | biostudies-literature
| S-EPMC10996855 | biostudies-literature
| S-EPMC7549921 | biostudies-literature
| S-EPMC3317112 | biostudies-literature
| S-EPMC8767326 | biostudies-literature
| S-EPMC9481898 | biostudies-literature